Pathstone Holdings’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Pathstone Holdings's HALO Position: Q2 2026 in Review
Pathstone Holdings increased its Halozyme (HALO) stake by 3% in Q2 2026, buying an estimated $17.1K and bringing the position to 8,620 shares worth $675K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.
Pathstone Holdings first reported a position in HALO in Q1 2024 and has held it in 10 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Pathstone Holdings held 8,620 shares of Halozyme worth $675K as of Q2 2026.
- Pathstone Holdings bought 251 Halozyme shares in Q2 2026, an estimated $17.1K.
- Halozyme made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1716 holding.
- Pathstone Holdings first reported a position in Halozyme in Q1 2024 and has held it in 10 quarters since.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.